checkAd

     104  0 Kommentare Nicox Provides Video Update on Latest Developments - Seite 2


    Edison Investment Research Pooya Hemami      London, UK
    H.C. Wainwright & Co            Yi Chen                  New York, U.S.
    Kepler Cheuvreux                   Damien Choplain Paris, France

        The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current.  Nicox disavows any obligation to correct or to update the information contained in analyst reports. Contacts Nicox
    Gavin Spencer
    Executive Vice President, Chief Business Officer
    & Head of Corporate Development 
    T +33 (0)4 97 24 53 00
    communications@nicox.com Investors & Media
    United States & Europe
    LifeSci Advisors, LLC
    Mary-Ann Chang
    T +44 7483 284 853
    mchang@lifesciadvisors.com Media
    France
    LifeSci Advisors, LLC
    Sophie Baumont
    M +33 (0)6 27 74 74 49
    sophie@lifesciadvisors.com Forward-Looking Statements The information contained in this document may be modified without prior notice.  This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance.  These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.  Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.
    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Nicox Provides Video Update on Latest Developments - Seite 2 FOR INFORMATIONNicox Provides Video Update on Latest Developments  March 2, 2021 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today provided a brief video …